(www.glauconix-biosciences.com)
Glauconix Biosciences is a specialty pharma research company that uses an innovative platform technology to reduce the cost of ophthalmic drug development.
Early identification and validation of effective compounds or biologics, allows partners to confidently enter clinical trial.www.glauconix-biosciences.com Glauconix Biosciences is a specialty pharma research company that uses an innovative platform technology to reduce the cost of ophthalmic drug development. Glauconix operates out of its laboratories located at the SUNY Polytechnic Institute-Albany, NY campus. It collaborates with academic and industry partners to help screen, identify and validate the unique MOA of the most effective drug candidates. Glauconix’s 3D tissue system can reduce the risk of clinical trial failure; saving time, labor and development costs. Early identification and validation of effective compounds or biologics, allows partners to confidently enter clinical trial.
It has raised $100,000 for its glaucoma drug development technology. Excell Partners of Rochester is investing money into Glauconix which previously had obtained an investment from Eastern New York Angels. The company has a 3-D human eye tissue technology that can be used to test drugs.